Our results suggest that COVID-19 is causing upregulation of IgG production leading to activation of classical complement through C1S, which produces a downregulation of RUNX1 and TYK2 signaling, that blocks T-cell maturation and mutes Th1/Th17 immune response, respectively (Figure 2B). The gene discussed is RUNX1; the disease is COVID-19.